The most common risks of oral GLP-1s like Rybelsus, Wegovy pill, and Foundayo include : Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All three GLP-1s also carry a black box warning for thyroid tumors based on animal studies
Diarrhoea, abdominal pain, and reduced appetite are also commonly reported, reflecting the medication's effect on gastrointestinal motility and gastric emptying
the standard monthly tiers are roughly twice that
GLP-1 medications work partly by suppressing appetite and slowing gastric emptying. That's the mechanism behind the weight loss. But less food in means fewer vitamins and minerals in and the research now shows this isn't a theoretical concern. Butsch et al. (2025), the largest of the six studies in the Urbina review, tracked 461,382 GLP-1 users and found 22.4% had a new nutritional deficiency diagnosis within 12 months. Vitamin D was most common (13.6%), followed by nutritional anemia (4%), iron deficiency (3.2%), and B vitamin deficiency (2.6%). In a smaller dietary study (Johnson et al. 2025, Frontiers in Nutrition), 64% of GLP-1 users didn't meet iron intake recommendations, and 72% fell short on calcium.* This GLP-1 supplement covers the five most at-risk nutrients with bioavailable forms: methylcobalamin B12, chelated iron, chelated zinc, 5-MTHF folate, and vitamin D3
Glutamine directly affects muscle protein synthesis, the process by which muscle fibers heal and proliferate after being torn down during exercise
The viability of ApoA-I as a template for the development of peptidomimetic therapeutics has been corroborated by the observation that FAMP (Fukuoka University ApoA-I mimetic peptide) increases the biological function of HDL and exerts atheroprotective effects at the same time, leading to a reduction of aortic plaques of about 50% in ApoE knockout mice on a high-fat-diet [102]
